Shinsuke Hanatani

1.9k total citations
81 papers, 902 citations indexed

About

Shinsuke Hanatani is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Shinsuke Hanatani has authored 81 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 35 papers in Molecular Biology and 16 papers in Nephrology. Recurrent topics in Shinsuke Hanatani's work include Amyloidosis: Diagnosis, Treatment, Outcomes (28 papers), Cardiovascular Function and Risk Factors (20 papers) and Parathyroid Disorders and Treatments (16 papers). Shinsuke Hanatani is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (28 papers), Cardiovascular Function and Risk Factors (20 papers) and Parathyroid Disorders and Treatments (16 papers). Shinsuke Hanatani collaborates with scholars based in Japan, United States and Germany. Shinsuke Hanatani's co-authors include Satoshi Araki, Hisao Ogawa, Kenichi Tsujita, Yuichi Kimura, Seiji Takashio, Taku Rokutanda, Yasuhiro Izumiya, Koichi Kaikita, Eiichiro Yamamoto and Yasuhiro Izumiya and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Journal of the American Society of Nephrology.

In The Last Decade

Shinsuke Hanatani

68 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shinsuke Hanatani Japan 19 327 325 248 141 127 81 902
Jun Morinaga Japan 19 307 0.9× 374 1.2× 102 0.4× 118 0.8× 112 0.9× 63 995
Masahiro Koide Japan 15 223 0.7× 245 0.8× 92 0.4× 156 1.1× 74 0.6× 46 806
Jörg Heineke Germany 11 536 1.6× 468 1.4× 370 1.5× 65 0.5× 55 0.4× 15 1.4k
Taku Rokutanda Japan 10 227 0.7× 129 0.4× 155 0.6× 22 0.2× 40 0.3× 29 539
Jacques Djian France 5 644 2.0× 412 1.3× 74 0.3× 58 0.4× 216 1.7× 10 1.2k
Ahmed Fayyaz United States 9 328 1.0× 267 0.8× 56 0.2× 96 0.7× 211 1.7× 14 645
Masaaki Hoshiga Japan 21 572 1.7× 335 1.0× 133 0.5× 226 1.6× 328 2.6× 103 1.4k
Harutoshi Tamura Japan 16 426 1.3× 120 0.4× 73 0.3× 41 0.3× 95 0.7× 80 698
Stefan Stojković Austria 20 229 0.7× 263 0.8× 66 0.3× 74 0.5× 139 1.1× 58 917
J.-L. Dubois-Randé France 16 591 1.8× 176 0.5× 92 0.4× 57 0.4× 184 1.4× 43 950

Countries citing papers authored by Shinsuke Hanatani

Since Specialization
Citations

This map shows the geographic impact of Shinsuke Hanatani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinsuke Hanatani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinsuke Hanatani more than expected).

Fields of papers citing papers by Shinsuke Hanatani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinsuke Hanatani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinsuke Hanatani. The network helps show where Shinsuke Hanatani may publish in the future.

Co-authorship network of co-authors of Shinsuke Hanatani

This figure shows the co-authorship network connecting the top 25 collaborators of Shinsuke Hanatani. A scholar is included among the top collaborators of Shinsuke Hanatani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinsuke Hanatani. Shinsuke Hanatani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takashio, Seiji, Kyoko Hirakawa, Masanobu Ishii, et al.. (2025). Long-Term Effect of Tafamidis on Clinical Parameters and Prognostic Predictors in Patients With Transthyretin Amyloid Cardiomyopathy. Circulation Journal. 89(4). 421–431. 2 indexed citations
2.
Takashio, Seiji, Kyoko Hirakawa, Shinsuke Hanatani, et al.. (2024). Clinical characteristics of patients with high extracellular volume fraction evaluated by cardiac computed tomography for coronary artery evaluation. European Heart Journal Open. 4(3). oeae036–oeae036. 1 indexed citations
3.
Fujisue, Koichiro, Miwa Ito, Yasushi Matsuzawa, et al.. (2024). Open-Label, Single-Center, Single-Arm Study Evaluating the Efficacy and Safety of Elobixibat for Chronic Constipation in Patients With Heart Failure. Circulation Reports. 6(3). 55–63. 1 indexed citations
5.
Takashio, Seiji, Kôsuke Nakamura, Shinsuke Hanatani, et al.. (2024). Coexisting transthyretin and atrial natriuretic peptide amyloid on left atrium in transthyretin amyloid cardiomyopathy. Journal of Cardiology Cases. 29(6). 261–264. 2 indexed citations
6.
Araki, Satoshi, Koichi Kaikita, Nobuhiro Nakanishi, et al.. (2024). Mineralocorticoid Receptor Blocker Prevents Mineralocorticoid Receptor–Mediated Inflammation by Modulating Transcriptional Activity of Mineralocorticoid Receptor–p65–Signal Transducer and Activator of Transcription 3 Complex. Journal of the American Heart Association. 13(18). e030941–e030941. 1 indexed citations
7.
Takashio, Seiji, Kyoko Hirakawa, Masanobu Ishii, et al.. (2024). Cardiac Biomarker Change at 1 Year After Tafamidis Treatment and Clinical Outcomes in Patients With Transthyretin Amyloid Cardiomyopathy. Journal of the American Heart Association. 13(10). e034518–e034518. 7 indexed citations
8.
Usuku, Hiroki, Eiichiro Yamamoto, Fumi Oike, et al.. (2024). Prognostic value of left atrial stiffness in patients undergoing transcatheter aortic valve implantation. IJC Heart & Vasculature. 56. 101559–101559. 1 indexed citations
9.
Takashio, Seiji, Teiji Kato, Hiroki Irie, et al.. (2023). Prevalence of Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release With Amyloid Deposition. Circulation Journal. 87(8). 1047–1055. 7 indexed citations
10.
Usuku, Hiroki, Eiichiro Yamamoto, Daisuke Sueta, et al.. (2023). Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis. European Heart Journal Open. 3(3). oead048–oead048. 4 indexed citations
11.
Fujisue, Koichiro, Kenshi Yamanaga, Daisuke Sueta, et al.. (2023). Prognostic Significance of Soluble PD-L1 on Cardiovascular Outcomes in Patients with Coronary Artery Disease. Journal of Atherosclerosis and Thrombosis. 31(4). 355–367. 4 indexed citations
12.
Takashio, Seiji, Toshihiro Yamada, Kyoko Hirakawa, et al.. (2022). A Simple Staging System Using Biomarkers for Wild-Type Transthyretin Amyloid Cardiomyopathy in Japan. ESC Heart Failure. 9(3). 1731–1739. 8 indexed citations
13.
Sueta, Daisuke, Masafumi Kidoh, Mai Tomiguchi, et al.. (2022). Cardiac Computed Tomography-Derived Myocardial Tissue Characterization After Anthracycline Treatment. ESC Heart Failure. 9(3). 1792–1800. 4 indexed citations
14.
Yamada, Toshihiro, Toshifumi Ishida, Seiji Takashio, et al.. (2021). Abstract 11133: Endogenous Ketone Bodies Have Cardioprotective Effects in Obesity Related Heart Failure with Preserved Ejection Fraction. Circulation. 144(Suppl_1).
15.
Hanatani, Shinsuke, Yasuhiro Izumiya, Yoshiro Onoue, et al.. (2018). Non-invasive testing for sarcopenia predicts future cardiovascular events in patients with chronic kidney disease. International Journal of Cardiology. 268. 216–221. 45 indexed citations
16.
Hanatani, Shinsuke, Yasuhiro Izumiya, Satoshi Araki, et al.. (2014). Akt1-Mediated Fast/Glycolytic Skeletal Muscle Growth Attenuates Renal Damage in Experimental Kidney Disease. Journal of the American Society of Nephrology. 25(12). 2800–2811. 47 indexed citations
17.
Hanatani, Shinsuke, Yasuhiro Izumiya, Satoshi Araki, et al.. (2012). Abstract 11021: Akt1-mediated Skeletal Muscle Growth Attenuates Renal Interstitial Fibrosis and Inflammation in Obstructive Nephropathy. Circulation. 126. 1 indexed citations
18.
Hanatani, Shinsuke, Yasuhiro Izumiya, Satoshi Araki, et al.. (2011). Abstract 9679: Fast/Glycolytic Skeletal Muscle Growth Attenuates Cardiac Dysfunction and Remodeling After Experimental Myocardial Infarction. Circulation. 124(suppl_21). 1 indexed citations
19.
Araki, Satoshi, Yasuhiro Izumiya, Takafumi Senokuchi, et al.. (2011). Abstract 9663: Sirt7 Contributes to Proper Wound Healing After Murine Model of Myocardial Infarction by Modulating the Fibroblast Differentiation. Circulation. 124(suppl_21). 1 indexed citations
20.
Oshima, Shuichi, et al.. (2010). PHARMACODYNAMIC EFFECTS AND CLINICAL OUTCOMES OF CLOPIDOGREL AND TICLOPIDINE WITH OR WITHOUT A PROTON-PUMP INHIBITOR. Journal of the American College of Cardiology. 55(10). A50.E473–A50.E473. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026